Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Biotechnology
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
TSX:GUD - Post Discussion
Knight Therapeutics Inc
> Even Goodman's charity ... designed for long-term success
New Post
View:
Discussion
List
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Apr 07, 2022 8:44am
Even Goodman's charity ... designed for long-term success
As executive chair of Knight Therapeutics, which markets and licenses drugs from international drugmakers for Canada and Latin America, Goodman is still deeply involved in the world of pharmaceuticals and remains dedicated to helping others through his philanthropy. “Ironically, selling drugs pays for my tzedakah habit,” he jokes.
https://www.jpost.com/israel-news/article-703509
On a more serious note, he adds that the word “recovery” is not the right term for a traumatic brain injury. “I will never recover, and I will never be who I was. But I am smart enough and driven enough to make a difference in this world.”
(5)
•••
PitchinPennies
X
View Profile
View Bullboard History
Comment by
PitchinPennies
on Apr 07, 2022 10:41am
That life-changing konk on the noggin obviously didn't affect the portion of JRG's brain that governs his hubris level. He's got plenty of that in spades, along with a surfeit of hauteur, pomposity, and just a smidge of superciliousness. I could overlook all those annoying traits if he'd just go out and make me some money. Of course that hasn't happened, maybe because he
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Apr 07, 2022 2:29pm
Just to add ... And he knew when it was time to back away from day-to-day so he can focus on strategy while also dedicating time to what the rich do ... playing robinhood !!!! That's the way it should be!
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Apr 07, 2022 3:40pm
Pinching pennies, glad you are picking up the baton a bit on this forum, it is sure tiring to keep responding to peddlers who have lost fortunes, the shirts and taken it on the chin by investing on GUD. They are like a pest in a financial plague looking for other bad losers like themselves to bail them out of their bad investment decisions. I may be back if sporadically as spring is around the
...more
(5)
•••
PitchinPennies
X
View Profile
View Bullboard History
Comment by
PitchinPennies
on Apr 08, 2022 9:34am
Caveat Emptor is generally sound advice in any situation. I was an early buyer of GUD based on a compelling story. The story seemed to be entirely about one man: the magical JRG. I liked the story, and, in spite of his oddness, or perhaps because of it, I liked the man. Ten years on, I'm not at all reassured by the recent news item that he believes his work in pharma is only a means of
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Apr 08, 2022 10:08am
Ya - I don't judge Goodman for the person he is - there are many sides to him and he's juggled them well. I don't judge him for his accident as he's still more capable than most. I do like that he turned over the reigns as doing so is very difficult for a controlling person. I give him credit for knowing when it's time to walk away from day-to-day. Also - he
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments